Balance Sheet

Cash Flow Statement

Amortization of Goodwill Amortization of Goodwill Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Stran & Company (SWAG) Asset Writedowns and Impairment (2022 - 2023)

Stran & Company (SWAG) has disclosed Asset Writedowns and Impairment for 2 consecutive years, with $77149.0 as the latest value for Q4 2023.

Quarterly Asset Writedowns and Impairment fell 24.94% to $77149.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was -$65000.0 through Dec 2023, down 280.56% year-over-year, with the annual reading at -$65000.0 for FY2023, 280.56% down from the prior year.
Asset Writedowns and Impairment hit $77149.0 in Q4 2023 for Stran & Company, up from -$74437.0 in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $102785.0 in Q4 2022 to a low of -$74437.0 in Q3 2023.